<?xml version="1.0" encoding="UTF-8"?>
<ref id="B138-vaccines-08-00273">
 <label>138.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Fenimore</surname>
    <given-names>P.W.</given-names>
   </name>
   <name>
    <surname>Muhammad</surname>
    <given-names>M.A.</given-names>
   </name>
   <name>
    <surname>Fischer</surname>
    <given-names>W.M.</given-names>
   </name>
   <name>
    <surname>Foley</surname>
    <given-names>B.T.</given-names>
   </name>
   <name>
    <surname>Bakken</surname>
    <given-names>R.R.</given-names>
   </name>
   <name>
    <surname>Thurmond</surname>
    <given-names>J.R.</given-names>
   </name>
   <name>
    <surname>Yusim</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Yoon</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Parker</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Hart</surname>
    <given-names>M.K.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Designing and testing broadly-protective filoviral vaccines optimized for cytotoxic T-lymphocyte epitope coverage</article-title>
  <source>PLoS ONE</source>
  <year>2012</year>
  <volume>7</volume>
  <elocation-id>e44769</elocation-id>
  <pub-id pub-id-type="doi">10.1371/journal.pone.0044769</pub-id>
  <pub-id pub-id-type="pmid">23056184</pub-id>
 </element-citation>
</ref>
